3/27/2014

GlaxoSmithKline announced Wednesday that reports of tampering with its weight-loss drug Alli have surfaced. Consumers have reported problems with about 20 bottles of the drug purchased in seven states, most in the South. The FDA is investigating, GSK noted.

Full Story:
Reuters

Related Summaries